期刊文献+

常规放疗与伽玛刀加常规放疗治疗鼻咽癌130例临床分析

Clinical analysis of 130 cases of nasopharyngeal carcinoma treated with conventional radiotherapy and gamma knife plus conventional radiotherapy
下载PDF
导出
摘要 目的探讨鼻咽癌(NPC)的放疗方式及预后。方法对130例NPC患者临床资料进行回顾性分析。根据放疗方法的不同分为常规放疗(CRT)组100例、伽玛刀(GKS)+CRT组30例,分析不同放疗方法的并发症、局部控制率和生存率。结果 CRT组与GKS+CRT组晚期并发症发生率比较无统计学差异;1、3年生存率分别为99%、90%与96.7%、92%,两组比较均无统计学差异;局部复发率分别为18%、3.3%,两组比较有统计学差异(P<0.05)。结论 GKS+CRT治疗鼻咽癌,不增加患者并发症、可减少复发、提高患者生活质量。 Objective To study radiotherapy for nasopharyngeal carcinoma (NPC) and its prognosis. Methods Clinical data of 130 patients with NPC were retrospectively reviewed. According to treatment modalities, the patients were divided into conventional radiotherapy (CRT) group ( n = 100) and gamma knife radiosurgery (GKS) plus CRT group ( n = 30 ). Complication rate, survival rate and locally recurrent rate were compared between the two groups. Results There was no significant difference in complication rate between CRT group and GKS plus CRT group. The survival rates of the two groups were 99.0% and 96.7% (1-year) and 90.0% and 92.0% (3-year) , respectively, and there were no significant difference, either. The locally recurrent rates were 18.0% in CRT group and 3.3% in GKS plus CRT group, between which there was a significant difference (P 〈 0.05 ). Conclusion Without increasing complication, GKS plus CRT can reduce locally recurrent rate and improve quality of patients with NPC.
机构地区 解放军第
出处 《临床军医杂志》 CAS 2013年第2期183-184,共2页 Clinical Journal of Medical Officers
关键词 鼻咽癌 常规放疗 伽玛刀 nasopharyngeal carcinoma conventional radiotherapy gamma knife radiosurgery
  • 相关文献

参考文献4

二级参考文献24

  • 1刘学奎,曾宗渊,洪明晃,崔念基,苏勇,麦海强,陈福进.颌下腺移位术预防鼻咽癌放疗后口干燥症的近期效果[J].癌症,2005,24(5):577-581. 被引量:17
  • 2卢泰祥,赵充,吴少雄,罗伟,陈勇,谢方云,陈明,曾祥发,胡伟汉,曹新平,夏云飞,刘秀芳,崔念基.鼻咽癌单纯常规外照射放疗疗效的分析[J].中华肿瘤杂志,2005,27(10):620-622. 被引量:90
  • 3赵充,卢泰祥,韩非,卢丽霞,黄劭敏,邓小武,林承光,崔念基.139例鼻咽癌调强放疗的临床研究[J].中华放射肿瘤学杂志,2006,15(1):1-6. 被引量:154
  • 4孔琳,张有望,吴永如,郭小毛.鼻咽癌放疗后长期生存者晚期副反应研究[J].中华放射肿瘤学杂志,2006,15(3):153-156. 被引量:72
  • 5Le QT,Tare D,Koong A,et al.Improve local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma[J].Int J Radiation Oncol Bid Phys,2003,56(4):1046-1058.
  • 6Kam MK,Chau RM,Petruzzli GJ,et al.Intensity-modulated radiotherapy in nasopharyngeal carcinoma:dosimeticadvantage over conventional plans and feasibility of doseescalation[J].Int J Radiat Oncol Biol PIlys,2003,56:145-157.
  • 7Cozzi L,Fogliata A,Bolsi A,et al.Three-demensional conformal vs.intensity-modulated radiotherapy in head and neck cancer patients:comparative analysis of dosimetric and technical parameters[J].Int J Radial,Oncol Biol Plays,2004,58:617-624.
  • 8Cox JD,Stetz J,Pajak TF.Toxicity criteria of the Radiation Therapy Oncology Group(RTOG) and the European Organization for Research ang Treatment of Cancer(EORTC)[J].Int J Radiat Oncol Biol Phys,1995,31:1341-1346.
  • 9Lee AWM,Sze WM,Au JSK,et al.Treatment results of nasopharyngeal carcinoma in the modem ear:the Hong Kong experience[J].Int J Radiat Oncol Biol Phys,2005,61 (4):1107-1116.
  • 10Yeh SA,Tang Y,Lui CC,et al.Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone[J].Int J Radiat Oncol Biol Phys,2005,62:672-679.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部